Jack Ball, Director at Cytek Biosciences, Inc. (CTKB), sold 16,000 shares at $14.69 ($235K) on 2022-11-14, disclosed to the SEC on 2022-11-16.
Open-market sale of $235k CTKB by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.